Study:
  study_phase:
    conceptId: C66737
    definition: A terminology codelist relevant to the phase, or stage, of the clinical
      trial.
    extensible: 'true'
    name: Trial Phase Response
    preferredTerm: CDISC SDTM Trial Phase Terminology
    submissionValue: TPHASE
    synonyms:
    - Trial Phase Response
    terms:
    - conceptId: C48660
      definition: Determination of a value is not relevant in the current context.
        (NCI)
      preferredTerm: Not Applicable
      submissionValue: NOT APPLICABLE
      synonyms:
      - NA
      - Not Applicable
    - conceptId: C54721
      definition: 'First-in-human trials, in a small number of subjects, that are
        conducted before Phase 1 trials and are intended to assess new candidate therapeutic
        and imaging agents. The study agent is administered at a low dose for a limited
        time, and there is no therapeutic or diagnostic intent. NOTE: FDA Guidance
        for Industry, Investigators, and Reviewers: Exploratory IND Studies, January
        2006 classifies such studies as Phase 1. NOTE: A Phase 0 study might not include
        any drug delivery but may be an exploration of human material from a study
        (e.g., tissue samples or biomarker determinations). [Improving the Quality
        of Cancer Clinical Trials: Workshop summary-Proceedings of the National Cancer
        Policy Forum Workshop, improving the Quality of Cancer Clinical Trials (Washington,
        DC, Oct 2007)] (CDISC glossary)'
      preferredTerm: Phase 0 Trial
      submissionValue: PHASE 0 TRIAL
      synonyms:
      - '0'
      - Pre-clinical Trial
      - Trial Phase 0
    - conceptId: C15600
      definition: 'The initial introduction of an investigational new drug into humans.
        Phase 1 studies are typically closely monitored and may be conducted in patients
        or normal volunteer subjects. NOTE: These studies are designed to determine
        the metabolism and pharmacologic actions of the drug in humans, the side effects
        associated with increasing doses, and, if possible, to gain early evidence
        on effectiveness. During Phase 1, sufficient information about the drug''s
        pharmacokinetics and pharmacological effects should be obtained to permit
        the design of well-controlled, scientifically valid, Phase 2 studies. The
        total number of subjects and patients included in Phase I studies varies with
        the drug, but is generally in the range of 20 to 80. Phase 1 studies also
        include studies of drug metabolism, structure-activity relationships, and
        mechanism of action in humans, as well as studies in which investigational
        drugs are used as research tools to explore biological phenomena or disease
        processes. [After FDA CDER Handbook, ICH E8] (CDISC glossary)'
      preferredTerm: Phase I Trial
      submissionValue: PHASE I TRIAL
      synonyms:
      - '1'
      - Trial Phase 1
    - conceptId: C15693
      definition: A class of clinical study that combines elements characteristic
        of traditional Phase I and Phase II trials. See also Phase I, Phase II.
      preferredTerm: Phase I/II Trial
      submissionValue: PHASE I/II TRIAL
      synonyms:
      - 1-2
      - Trial Phase 1-2
    - conceptId: C15601
      definition: 'Phase 2. Controlled clinical studies conducted to evaluate the
        effectiveness of the drug for a particular indication or indications in patients
        with the disease or condition under study and to determine the common short-term
        side effects and risks associated with the drug. NOTE: Phase 2 studies are
        typically well controlled, closely monitored, and conducted in a relatively
        small number of patients, usually involving no more than several hundred subjects.
        [After FDA CDER Handbook, ICH E8] (CDISC glossary)'
      preferredTerm: Phase II Trial
      submissionValue: PHASE II TRIAL
      synonyms:
      - '2'
      - Trial Phase 2
    - conceptId: C15694
      definition: A class of clinical study that combines elements characteristic
        of traditional Phase II and Phase III trials.
      preferredTerm: Phase II/III Trial
      submissionValue: PHASE II/III TRIAL
      synonyms:
      - 2-3
      - Trial Phase 2-3
    - conceptId: C49686
      definition: A clinical research protocol generally referred to as a pilot or
        feasibility trial that aims to prove the concept of the new intervention in
        question. (NCI)
      preferredTerm: Phase IIa Trial
      submissionValue: PHASE IIA TRIAL
      synonyms:
      - 2A
      - Trial Phase 2A
    - conceptId: C49688
      definition: A clinical research protocol generally referred to as a well-controlled
        and pivotal trial that aims to prove the mechanism of action of the new intervention
        in question. A pivotal study will generally be well-controlled, randomized,
        of adequate size, and whenever possible, double-blind. (NCI)
      preferredTerm: Phase IIb Trial
      submissionValue: PHASE IIB TRIAL
      synonyms:
      - 2B
      - Trial Phase 2B
    - conceptId: C15602
      definition: 'Phase 3. Studies are expanded controlled and uncontrolled trials.
        They are performed after preliminary evidence suggesting effectiveness of
        the drug has been obtained, and are intended to gather the additional information
        about effectiveness and safety that is needed to confirm efficacy and evaluate
        the overall benefit-risk relationship of the drug and to provide an adequate
        basis for physician labeling. NOTE: Phase 3 studies usually include from several
        hundred to several thousand subjects. [After FDA CDER Handbook, ICH E8] (CDISC
        glossary)'
      preferredTerm: Phase III Trial
      submissionValue: PHASE III TRIAL
      synonyms:
      - '3'
      - Trial Phase 3
    - conceptId: C49687
      definition: A classification typically assigned retrospectively to a Phase III
        trial upon determination by regulatory authorities of a need for a Phase III
        B trial. (NCI)
      preferredTerm: Phase IIIa Trial
      submissionValue: PHASE IIIA TRIAL
      synonyms:
      - 3A
      - Trial Phase 3A
    - conceptId: C49689
      definition: 'A subcategory of Phase III trials done near the time of approval
        to elicit additional findings. NOTE: Dossier review may continue while associated
        Phase IIIB trials are conducted. These trials may be required as a condition
        of regulatory authority approval.'
      preferredTerm: Phase IIIb Trial
      submissionValue: PHASE IIIB TRIAL
      synonyms:
      - 3B
      - Trial Phase 3B
    - conceptId: C15603
      definition: 'Phase 4. Postmarketing (Phase 4) studies to delineate additional
        information about the drug''s risks, benefits, and optimal use that may be
        requested by regulatory authorities in conjunction with marketing approval.
        NOTE: These studies could include, but would not be limited to, studying different
        doses or schedules of administration than were used in Phase 2 studies, use
        of the drug in other patient populations or other stages of the disease, or
        use of the drug over a longer period of time. [After FDA CDER Handbook, ICH
        E8] (CDISC glossary)'
      preferredTerm: Phase IV Trial
      submissionValue: PHASE IV TRIAL
      synonyms:
      - '4'
      - Trial Phase 4
    - conceptId: C47865
      definition: Postmarketing surveillance is sometimes referred to as Phase V.
      preferredTerm: Phase V Trial
      submissionValue: PHASE V TRIAL
      synonyms:
      - '5'
      - Trial Phase 5
  study_type:
    conceptId: C99077
    definition: A terminology codelist relevant to the role the study plays in determining
      the interventions a subject receives.
    extensible: 'false'
    name: Study Type Response
    preferredTerm: CDISC SDTM Study Type Terminology
    submissionValue: STYPE
    synonyms:
    - Study Type Response
    terms:
    - conceptId: C98722
      definition: Studies that provide a means for obtaining an experimental drug
        or device for patients who are not adequately treated by existing therapy,
        who do not meet the eligibility criteria for enrollment, or who are otherwise
        unable to participate in another clinical study. Expanded Access studies include
        individual-patient IND, treatment IND, compassionate use, emergency use or
        continued access.
      preferredTerm: Expanded Access Study
      submissionValue: EXPANDED ACCESS
    - conceptId: C98388
      definition: Studies in which individuals are assigned by an investigator based
        on a protocol to receive specific interventions. Subjects may receive diagnostic,
        therapeutic or other types of interventions. The assignment of the intervention
        may or may not be random. The individuals are then followed and biomedical
        and/or health outcomes are assessed.
      preferredTerm: Interventional Study
      submissionValue: INTERVENTIONAL
    - conceptId: C16084
      definition: Studies in which biomedical and/or health outcomes are assessed
        in pre-defined groups of individuals. Subjects in the study may receive diagnostic,
        therapeutic, or other interventions, but the investigator does not assign
        specific interventions to the subjects of the study.
      preferredTerm: Observational Study
      submissionValue: OBSERVATIONAL
    - conceptId: C129000
      definition: Observational studies which include an organized system that uses
        observational methods to collect uniform data (clinical and other) prospectively
        for a population defined by a particular disorder/disease, condition (including
        susceptibility to a disorder), or exposure (including products, health care
        services, and/or procedures) and that serves a predetermined scientific, clinical,
        or policy purpose. Patient registries may be single purpose or on-going data
        collection programs that address one or more questions. (AHRQ)
      preferredTerm: Patient Registry Study
      submissionValue: PATIENT REGISTRY
StudyArm:
  study_arm_type:
    conceptId: C174222
    definition: The terminology relevant to the identification of the kind of arm.
    name: Study Arm Type Value Set Terminology
    preferredTerm: CDISC Protocol Study Arm Type Value Set Terminology
    submissionValue: Study Arm Type Value Set Terminology
    synonyms:
    - Study Arm Type Value Set Terminology
    terms:
    - conceptId: C174267
      definition: An arm describing the active comparator.
      preferredTerm: Active Comparator Arm
      submissionValue: Active Comparator Arm
    - conceptId: C174226
      definition: An arm describing the intervention or treatment plan for a group
        of participants in the study receiving a control. The control may comprise
        a non-investigational product (active control) or regimen, placebo, or no
        treatment.
      preferredTerm: Control Arm
      submissionValue: Control Arm
    - conceptId: C174266
      definition: An arm describing the intervention or treatment plan for a group
        of participants in the study receiving test product(s).
      preferredTerm: Investigational Arm
      submissionValue: Experimental Arm
      synonyms:
      - Investigational Arm
    - conceptId: C174270
      definition: A study arm without an intervention or treatment.
      preferredTerm: No Intervention Arm
      submissionValue: No Intervention Arm
    - conceptId: C174268
      definition: An arm describing the placebo comparator.
      preferredTerm: Placebo Control Arm
      submissionValue: Placebo Comparator Arm
      synonyms:
      - Placebo Control Arm
    - conceptId: C174269
      definition: An arm describing the sham comparator.
      preferredTerm: Sham Comparator Arm
      submissionValue: Sham Comparator Arm
      synonyms:
      - Sham Intervention Arm
    - conceptId: C15538
      definition: An arm describing the intervention or treatment plan for a group
        of participants in the study. Treatment may consist of either experimental
        or control products under investigation.
      preferredTerm: Protocol Treatment Arm
      submissionValue: Treatment Arm
StudyDesign:
  trial_intent_type:
    conceptId: C66736
    definition: A terminology codelist relevant to the responses for the planned purpose
      of the therapy, device, or agent under study in the clinical trial.
    extensible: 'true'
    name: Trial Intent Type Response
    preferredTerm: CDISC SDTM Trial Indication Type Terminology
    submissionValue: TINDTP
    synonyms:
    - Trial Intent Type Response
    terms:
    - conceptId: C15714
      definition: A type of study designed to examine the basic mechanism of action
        (e.g., physiology, biomechanics) of an intervention. (ClinicalTrials.gov)
      preferredTerm: Basic Research
      submissionValue: BASIC SCIENCE
      synonyms:
      - Basic Research
    - conceptId: C49654
      definition: A type of study designed to evaluate intervention(s) aimed to cure
        a disease or condition.
      preferredTerm: Cure Study
      submissionValue: CURE
    - conceptId: C139174
      definition: An intervention of a device product is being evaluated to determine
        the feasibility of the product or to test a prototype device and not health
        outcomes. Such studies are conducted to confirm the design and operating specifications
        of a device before beginning a full clinical trial. (ClinicalTrials.gov)
      preferredTerm: Device Feasibility Study
      submissionValue: DEVICE FEASIBILITY
    - conceptId: C49653
      definition: A type of study designed to evaluate intervention(s) aimed at identifying
        a disease or condition.
      preferredTerm: Diagnosis Study
      submissionValue: DIAGNOSIS
    - conceptId: C170629
      definition: A type of study designed to evaluate the effects of treatment(s)
        intended to cause a change in disease, syndrome, or condition beyond the point
        of treatment administration.
      preferredTerm: Disease Modifying Treatment Study
      submissionValue: DISEASE MODIFYING
    - conceptId: C15245
      definition: A type of study designed to evaluate the delivery, processes, management,
        organization or financing of health care. (ClinicalTrials.gov)
      preferredTerm: Health Services Research
      submissionValue: HEALTH SERVICES RESEARCH
    - conceptId: C49655
      definition: A type of study designed to identify actions necessary to eliminate
        or reduce the risk to human life or well-being as a result of a particular
        medication or treatment regimen. (NCI)
      preferredTerm: Adverse Effect Mitigation Study
      submissionValue: MITIGATION
    - conceptId: C49657
      definition: A type of study designed to identify actions necessary to permanently
        eliminate or reduce the long-term risk to human life as a result of a particular
        medication or treatment regimen.
      preferredTerm: Prevention Study
      submissionValue: PREVENTION
      synonyms:
      - Prophylaxis Study
    - conceptId: C71485
      definition: A type of study designed to assess or examine methods of identifying
        a condition (or risk factors for a condition) in people who are not yet known
        to have the condition (or risk factor). (Clinicaltrials.gov)
      preferredTerm: Screening Study
      submissionValue: SCREENING
    - conceptId: C71486
      definition: A type of study designed to evaluate one or more interventions where
        the primary intent is to maximize comfort, minimize side effects or mitigate
        against a decline in the subject's health or function. In general, supportive
        care interventions are not intended to cure a disease. (ClinicalTrials.gov)
      preferredTerm: Supportive Care Study
      submissionValue: SUPPORTIVE CARE
    - conceptId: C49656
      definition: A type of study designed to evaluate intervention(s) for treatment
        of disease, syndrome or condition.
      preferredTerm: Treatment Study
      submissionValue: TREATMENT
      synonyms:
      - Therapy Trial
  trial_type:
    conceptId: C66739
    definition: A terminology codelist relevant to the type of primary outcome or
      endpoint that the protocol is designed to evaluate.
    extensible: 'true'
    name: Trial Type Response
    preferredTerm: CDISC SDTM Trial Type Terminology
    submissionValue: TTYPE
    synonyms:
    - Trial Type Response
    terms:
    - conceptId: C158283
      definition: A type of study designed to evaluate the strength of the bond between
        an adhesive and the application surface.
      preferredTerm: Adhesion Performance Study
      submissionValue: ADHESION PERFORMANCE
    - conceptId: C158284
      definition: A type of study designed to evaluate the effects of alcohol on investigational
        product safety and/or efficacy.
      preferredTerm: Alcohol Effect Study
      submissionValue: ALCOHOL EFFECT
    - conceptId: C49664
      definition: A study of the degree to which or rate at which a drug or other
        substance is absorbed or becomes available at the site of physiological activity
        after administration. (NCI)
      preferredTerm: Bioavailability Study
      submissionValue: BIO-AVAILABILITY
    - conceptId: C49665
      definition: A study most often used to compare the efficacy of different formulations
        to treat a given disease. It is the testing of an old versus a new formulation
        in healthy volunteers or subjects with the disease under study and usually
        in one dose. (NCI)
      preferredTerm: Therapeutic Equivalency Study
      submissionValue: BIO-EQUIVALENCE
    - conceptId: C158288
      definition: A type of study designed to evaluate whether a biologic test article
        is highly similar in function and effect to an existing biologic that has
        already been clinically tested and approved for use.
      preferredTerm: Biosimilarity Study
      submissionValue: BIOSIMILARITY
    - conceptId: C158285
      definition: A type of study designed to evaluate the interaction between a device
        and a drug, where the use of one may affect the disposition, function, efficacy,
        or safety of the other.
      preferredTerm: Device-Drug Interaction Study
      submissionValue: DEVICE-DRUG INTERACTION
    - conceptId: C49653
      definition: A type of study designed to evaluate intervention(s) aimed at identifying
        a disease or condition.
      preferredTerm: Diagnosis Study
      submissionValue: DIAGNOSIS
    - conceptId: C158289
      definition: An early phase clinical study with the objective of determining
        the optimal dose of an investigational product.
      preferredTerm: Dose Finding Study
      submissionValue: DOSE FINDING
    - conceptId: C158290
      definition: A type of study designed to evaluate the relationship between dose
        and resulting exposure.
      preferredTerm: Dose Proportionality Study
      submissionValue: DOSE PROPORTIONALITY
    - conceptId: C127803
      definition: A study of the effect of dose changes on the efficacy of a drug
        in order to determine the dose-response relationship and optimal dose of a
        therapy.
      preferredTerm: Dose Response Study
      submissionValue: DOSE RESPONSE
    - conceptId: C158286
      definition: A type of study designed to evaluate the interaction between drugs,
        where the use of one may affect the disposition, efficacy, or safety of the
        other.
      preferredTerm: Drug-Drug Interaction Study
      submissionValue: DRUG-DRUG INTERACTION
    - conceptId: C178057
      definition: A study that evaluates the effect of a treatment on cardiac electrical
        activity, as assessed by electrocardiography.
      preferredTerm: Electrocardiographic Study
      submissionValue: ECG
      synonyms:
      - Electrocardiographic Study
    - conceptId: C49666
      definition: A study of the relative therapeutic efficacy of treatment of a disease.
        Usually this is a Phase II or III study. (NCI)
      preferredTerm: Efficacy Study
      submissionValue: EFFICACY
    - conceptId: C98729
      definition: Studies that are conducted to assess the effect of food on the rate
        and extent of absorption of a drug, either compared to a fasted state or to
        a reference drug.
      preferredTerm: Food Effect Study
      submissionValue: FOOD EFFECT
    - conceptId: C120842
      definition: A study that assesses an agent's ability to provoke an immune response.
      preferredTerm: Immunogenicity Study
      submissionValue: IMMUNOGENICITY
    - conceptId: C49662
      definition: A study of the biochemical and physiological effect of a drug and
        the mechanism of drug action and the relationship between drug concentration
        and effect. (NCI)
      preferredTerm: Pharmacodynamic Study
      submissionValue: PHARMACODYNAMIC
    - conceptId: C39493
      definition: A study that assesses the value associated with a given drug in
        therapeutic and economic terms. This type of study is multidisciplinary in
        nature and takes into consideration the social and economic costs (resource
        utilization costs including direct, indirect, and intangible costs) of drug
        therapy in addition to its direct therapeutic benefits. Analyses relate the
        difference in therapeutic benefits to the difference in costs between treatment
        alternatives. (NCI)
      preferredTerm: Pharmacoeconomic Study
      submissionValue: PHARMACOECONOMIC
    - conceptId: C129001
      definition: A study that assesses variation in DNA sequence, usually within
        a single gene, and its effect on drug response.
      preferredTerm: Pharmacogenetic Study
      submissionValue: PHARMACOGENETIC
    - conceptId: C49661
      definition: A study that identifies or assesses variations within the entire
        genome, including DNA, RNA, or transcriptional elements, and its effects on
        drug response.
      preferredTerm: Pharmacogenomic Study
      submissionValue: PHARMACOGENOMIC
    - conceptId: C49663
      definition: A study of the process by which a drug is absorbed, distributed,
        metabolized, and eliminated by the body. (NCI)
      preferredTerm: Pharmacokinetic Study
      submissionValue: PHARMACOKINETIC
    - conceptId: C161477
      definition: A type of study designed to evaluate the effect of body position
        during and/or after administration of the investigational product.
      preferredTerm: Position Effect Trial
      submissionValue: POSITION EFFECT
    - conceptId: C49657
      definition: A type of study designed to identify actions necessary to permanently
        eliminate or reduce the long-term risk to human life as a result of a particular
        medication or treatment regimen.
      preferredTerm: Prevention Study
      submissionValue: PREVENTION
      synonyms:
      - Prophylaxis Study
    - conceptId: C174366
      definition: A type of study designed to evaluate the expected, acute types of
        immunological responses, sometimes considered excessive, following agent administration.
      preferredTerm: Reactogenicity Study
      submissionValue: REACTOGENICITY
    - conceptId: C49667
      definition: A study that assesses the medical risks to a subject. Safety is
        usually assessed by examining a wide range of clinical parameters, including
        adverse events, vital signs, physical exam, laboratory tests.
      preferredTerm: Safety Study
      submissionValue: SAFETY
    - conceptId: C161478
      definition: A type of study designed to evaluate the effect of the investigational
        product on the physiologic act of swallowing.
      preferredTerm: Swallowing Function Trial
      submissionValue: SWALLOWING FUNCTION
    - conceptId: C158287
      definition: A type of study designed to evaluate the ability of an investigational
        product and/or approved drug to delay cardiac ventricular repolarization as
        detected by QT prolongation and other ECG parameters.
      preferredTerm: Thorough QT Study
      submissionValue: THOROUGH QT
      synonyms:
      - TQT Study
    - conceptId: C98791
      definition: A type of safety study that assesses the degree to which overt adverse
        effects can be tolerated by the subject.
      preferredTerm: Tolerability Study
      submissionValue: TOLERABILITY
    - conceptId: C49656
      definition: A type of study designed to evaluate intervention(s) for treatment
        of disease, syndrome or condition.
      preferredTerm: Treatment Study
      submissionValue: TREATMENT
      synonyms:
      - Therapy Trial
    - conceptId: C161479
      definition: A type of study designed to evaluate the user experience with a
        product.
      preferredTerm: Usability Testing Study
      submissionValue: USABILITY TESTING
    - conceptId: C161480
      definition: A type of study designed to evaluate the effects of water on investigational
        product safety and/or efficacy.
      preferredTerm: Water Effect Trial
      submissionValue: WATER EFFECT
StudyEpoch:
  epoch_type:
    conceptId: C99079
    definition: The name of the EPOCH.
    extensible: 'true'
    name: Epoch
    preferredTerm: CDISC SDTM Epoch Terminology
    submissionValue: EPOCH
    synonyms:
    - Epoch
    terms:
    - conceptId: C125938
      definition: A period in a clinical study after eligibility has been met and
        before the start of treatment, at which baseline measurements are collected.
      preferredTerm: Baseline Epoch
      submissionValue: BASELINE
    - conceptId: C102255
      definition: A period in a clinical study during which subjects receive blinded
        therapeutic treatment.
      preferredTerm: Blinded Treatment Epoch
      submissionValue: BLINDED TREATMENT
    - conceptId: C123452
      definition: A period in a clinical study during which subjects receive continuation
        treatment.
      preferredTerm: Continuation Therapy Epoch
      submissionValue: CONTINUATION TREATMENT
      synonyms:
      - Continuation Phase
    - conceptId: C99158
      definition: A period in a clinical study during which information about the
        health status of an individual is obtained after study interventions have
        concluded.
      preferredTerm: Clinical Study Follow-up
      submissionValue: FOLLOW-UP
    - conceptId: C123453
      definition: A period in a clinical study during which subjects receive induction
        treatment.
      preferredTerm: Induction Therapy Epoch
      submissionValue: INDUCTION TREATMENT
      synonyms:
      - Induction Phase
      - Intensive Phase
    - conceptId: C16032
      definition: A period in a clinical study during which information about the
        health status of an individual is obtained long after study interventions
        have concluded.
      preferredTerm: Long-term Follow-up
      submissionValue: LONG-TERM FOLLOW-UP
    - conceptId: C165873
      definition: A period in a clinical study during which subjects are observed,
        without any planned intervention.
      preferredTerm: Observation Study Epoch
      submissionValue: OBSERVATION
    - conceptId: C102256
      definition: A period in a clinical study during which subjects receive open
        label therapeutic treatment.
      preferredTerm: Open Label Treatment Epoch
      submissionValue: OPEN LABEL TREATMENT
    - conceptId: C98779
      definition: A period in a clinical study that occurs before the commencement
        of the primary clinical study investigation, during which subjects may be
        assessed for suitability in the clinical study, withdrawn from existing therapy,
        trained in study methodology or evaluated for any other protocol-specified
        reason.
      preferredTerm: Run-in Period
      submissionValue: RUN-IN
    - conceptId: C48262
      definition: A period in a clinical study during which subjects are evaluated
        for participation in the study.
      preferredTerm: Trial Screening
      submissionValue: SCREENING
    - conceptId: C101526
      definition: A period in a study during which subjects are receiving investigational
        therapy or treatment.
      preferredTerm: Treatment Epoch
      submissionValue: TREATMENT
    - conceptId: C42872
      definition: A period of time during a study when a subject is taken off of the
        investigational therapy or treatment in order to reduce the amount of investigational
        product within the body.
      preferredTerm: Washout Period
      submissionValue: WASHOUT
